Toll Free : +1-855-465-4651 | (DE) : +49 322 210 92714 | (USA) : +1-386-310-3803 | Contact : sales@qygroup.biz

Search Market Research Reports from Top Publishers

Global Community Acquired Pneumonia (CAP) Market Professional Survey Report By Manufacturers, Key Regions, Product and Application 2018 - 2025

Oct-2018 | Published By : QYResearch | Category : Pharmaceuticals | Pages : 91

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

Global Community Acquired Pneumonia (CAP) Market Professional Survey Report By Manufacturers, Key Regions, Product and Application 2018 - 2025

Oct-2018 | Published By : QYResearch | Category : Pharmaceuticals | Pages : 91 | Format : PDF

Community-acquired pneumonia (CAP) refers to pneumonia (any of several lung diseases) contracted by a person with little contact with the healthcare system.
The market of CAP treatment and diagnosis in further segmented with respect to major geographies of North America, Europe, Asia-Pacific, and Latin America.
In 2017, the global Community Acquired Pneumonia (CAP) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

This report focuses on the global Community Acquired Pneumonia (CAP) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Community Acquired Pneumonia (CAP) development in United States, Europe and China.

The key players covered in this study
    Pfizer
    Astrazeneca
    Bioaegis Therapeutics
    Biotest
    C10 Pharma
    Kyorin Pharmaceutical
    Melinta Therapeutics
    Merck
    Nabriva Therapeutics
    Paratek Pharmaceuticals

Market segment by Type, the product can be split into
    Chest X-ray/Radiography
    Sputum Gram Stain and/or Culture
    Blood Cultures

Market segment by Application, split into
    Hospitals and Clinics
    Others

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Community Acquired Pneumonia (CAP) status, future forecast, growth opportunity, key market and key players.
    To present the Community Acquired Pneumonia (CAP) development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Community Acquired Pneumonia (CAP) are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
<pre>Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Community Acquired Pneumonia (CAP) Market Size Growth Rate by Type (2013-2025) 1.4.2 Chest X-ray/Radiography 1.4.3 Sputum Gram Stain and/or Culture 1.4.4 Blood Cultures 1.5 Market by Application 1.5.1 Global Community Acquired Pneumonia (CAP) Market Share by Application (2013-2025) 1.5.2 Hospitals and Clinics 1.5.3 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Community Acquired Pneumonia (CAP) Market Size 2.2 Community Acquired Pneumonia (CAP) Growth Trends by Regions 2.2.1 Community Acquired Pneumonia (CAP) Market Size by Regions (2013-2025) 2.2.2 Community Acquired Pneumonia (CAP) Market Share by Regions (2013-2018) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Community Acquired Pneumonia (CAP) Market Size by Manufacturers 3.1.1 Global Community Acquired Pneumonia (CAP) Revenue by Manufacturers (2013-2018) 3.1.2 Global Community Acquired Pneumonia (CAP) Revenue Market Share by Manufacturers (2013-2018) 3.1.3 Global Community Acquired Pneumonia (CAP) Market Concentration Ratio (CR5 and HHI) 3.2 Community Acquired Pneumonia (CAP) Key Players Head office and Area Served 3.3 Key Players Community Acquired Pneumonia (CAP) Product/Solution/Service 3.4 Date of Enter into Community Acquired Pneumonia (CAP) Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Community Acquired Pneumonia (CAP) Market Size by Type (2013-2018) 4.2 Global Community Acquired Pneumonia (CAP) Market Size by Application (2013-2018) 5 United States 5.1 United States Community Acquired Pneumonia (CAP) Market Size (2013-2018) 5.2 Community Acquired Pneumonia (CAP) Key Players in United States 5.3 United States Community Acquired Pneumonia (CAP) Market Size by Type 5.4 United States Community Acquired Pneumonia (CAP) Market Size by Application 6 Europe 6.1 Europe Community Acquired Pneumonia (CAP) Market Size (2013-2018) 6.2 Community Acquired Pneumonia (CAP) Key Players in Europe 6.3 Europe Community Acquired Pneumonia (CAP) Market Size by Type 6.4 Europe Community Acquired Pneumonia (CAP) Market Size by Application 7 China 7.1 China Community Acquired Pneumonia (CAP) Market Size (2013-2018) 7.2 Community Acquired Pneumonia (CAP) Key Players in China 7.3 China Community Acquired Pneumonia (CAP) Market Size by Type 7.4 China Community Acquired Pneumonia (CAP) Market Size by Application 8 Japan 8.1 Japan Community Acquired Pneumonia (CAP) Market Size (2013-2018) 8.2 Community Acquired Pneumonia (CAP) Key Players in Japan 8.3 Japan Community Acquired Pneumonia (CAP) Market Size by Type 8.4 Japan Community Acquired Pneumonia (CAP) Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Community Acquired Pneumonia (CAP) Market Size (2013-2018) 9.2 Community Acquired Pneumonia (CAP) Key Players in Southeast Asia 9.3 Southeast Asia Community Acquired Pneumonia (CAP) Market Size by Type 9.4 Southeast Asia Community Acquired Pneumonia (CAP) Market Size by Application 10 India 10.1 India Community Acquired Pneumonia (CAP) Market Size (2013-2018) 10.2 Community Acquired Pneumonia (CAP) Key Players in India 10.3 India Community Acquired Pneumonia (CAP) Market Size by Type 10.4 India Community Acquired Pneumonia (CAP) Market Size by Application 11 Central & South America 11.1 Central & South America Community Acquired Pneumonia (CAP) Market Size (2013-2018) 11.2 Community Acquired Pneumonia (CAP) Key Players in Central & South America 11.3 Central & South America Community Acquired Pneumonia (CAP) Market Size by Type 11.4 Central & South America Community Acquired Pneumonia (CAP) Market Size by Application 12 International Players Profiles 12.1 Pfizer 12.1.1 Pfizer Company Details 12.1.2 Company Description and Business Overview 12.1.3 Community Acquired Pneumonia (CAP) Introduction 12.1.4 Pfizer Revenue in Community Acquired Pneumonia (CAP) Business (2013-2018) 12.1.5 Pfizer Recent Development 12.2 Astrazeneca 12.2.1 Astrazeneca Company Details 12.2.2 Company Description and Business Overview 12.2.3 Community Acquired Pneumonia (CAP) Introduction 12.2.4 Astrazeneca Revenue in Community Acquired Pneumonia (CAP) Business (2013-2018) 12.2.5 Astrazeneca Recent Development 12.3 Bioaegis Therapeutics 12.3.1 Bioaegis Therapeutics Company Details 12.3.2 Company Description and Business Overview 12.3.3 Community Acquired Pneumonia (CAP) Introduction 12.3.4 Bioaegis Therapeutics Revenue in Community Acquired Pneumonia (CAP) Business (2013-2018) 12.3.5 Bioaegis Therapeutics Recent Development 12.4 Biotest 12.4.1 Biotest Company Details 12.4.2 Company Description and Business Overview 12.4.3 Community Acquired Pneumonia (CAP) Introduction 12.4.4 Biotest Revenue in Community Acquired Pneumonia (CAP) Business (2013-2018) 12.4.5 Biotest Recent Development 12.5 C10 Pharma 12.5.1 C10 Pharma Company Details 12.5.2 Company Description and Business Overview 12.5.3 Community Acquired Pneumonia (CAP) Introduction 12.5.4 C10 Pharma Revenue in Community Acquired Pneumonia (CAP) Business (2013-2018) 12.5.5 C10 Pharma Recent Development 12.6 Kyorin Pharmaceutical 12.6.1 Kyorin Pharmaceutical Company Details 12.6.2 Company Description and Business Overview 12.6.3 Community Acquired Pneumonia (CAP) Introduction 12.6.4 Kyorin Pharmaceutical Revenue in Community Acquired Pneumonia (CAP) Business (2013-2018) 12.6.5 Kyorin Pharmaceutical Recent Development 12.7 Melinta Therapeutics 12.7.1 Melinta Therapeutics Company Details 12.7.2 Company Description and Business Overview 12.7.3 Community Acquired Pneumonia (CAP) Introduction 12.7.4 Melinta Therapeutics Revenue in Community Acquired Pneumonia (CAP) Business (2013-2018) 12.7.5 Melinta Therapeutics Recent Development 12.8 Merck 12.8.1 Merck Company Details 12.8.2 Company Description and Business Overview 12.8.3 Community Acquired Pneumonia (CAP) Introduction 12.8.4 Merck Revenue in Community Acquired Pneumonia (CAP) Business (2013-2018) 12.8.5 Merck Recent Development 12.9 Nabriva Therapeutics 12.9.1 Nabriva Therapeutics Company Details 12.9.2 Company Description and Business Overview 12.9.3 Community Acquired Pneumonia (CAP) Introduction 12.9.4 Nabriva Therapeutics Revenue in Community Acquired Pneumonia (CAP) Business (2013-2018) 12.9.5 Nabriva Therapeutics Recent Development 12.10 Paratek Pharmaceuticals 12.10.1 Paratek Pharmaceuticals Company Details 12.10.2 Company Description and Business Overview 12.10.3 Community Acquired Pneumonia (CAP) Introduction 12.10.4 Paratek Pharmaceuticals Revenue in Community Acquired Pneumonia (CAP) Business (2013-2018) 12.10.5 Paratek Pharmaceuticals Recent Development 13 Market Forecast 2018-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2018-2025) 13.10 Market Size Forecast by Application (2018-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details</pre>


 Latest Research Reports